Adverum Biotechnologies Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Update – P&T Community

Posted: March 6, 2017 at 9:43 pm

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Update
P&T Community
The companies' research collaboration and license agreement, entered into in May 2014 for an initial period of three years, was created to discover, develop and commercialize novel gene therapy products for the treatment of ophthalmologic diseases.

and more »

Continued here:
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Update - P&T Community

Related Posts

Comments are closed.

Archives